Maynard Um
-
-
-
-
-
-
-
Tempest delivers manufacturing component for CAR-T therapy development
-
-
-
-
-
-
-
Tempest Therapeutics (TPST) files for 1.17M share offering by selling stockholders
-
-
-
-
-
-
-
Tempest Therapeutics (TPST) Announces 739K Share offering at $6.25/sh
-
-
-
-
-
-
-
Tempest Therapeutics (TPST) Receives FDA Study May Proceed Notice for Phase 2 Trial of TPST-1495
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Tempest Therapeutics (TPST)
-
-
-
-
-
466,150 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


